Use of RSPH9 for Prognostic Marker Diagnosis of Bladder Cancer

摘要

The present invention relates to a novel biomarker for the diagnosis of bladder cancer and a use thereof, and more particularly to a biomarker for diagnosis of non-muscle invasive bladder cancer (NMIBC) using expression characteristics according to a methylation pattern of RSPH9 gene And as a diagnostic marker for bladder cancer prognosis.;